Medical Legal Review Inc is categorized under Industry Specialist Consultants in Columbus, OH and active since 1993.
Medical Legal Review Inc was established in 1993, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Industry Specialist Consultants business, which does work in the B2B market, and is classified as a Industry Specialist Consultants, under code number 5416140 by the NAICS.
If you are seeking more information, feel free to contact Carol Vollberg, Owner at the company’s single location by writing to 580 South High St # 120, Columbus, Ohio OH 43215 or by phoning (614) 224-8900. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Medical Legal Review Inc |
Contact Person: | Carol Vollberg, Owner |
Address: | 580 South High St # 120, Columbus, Ohio 43215 |
Phone Number: | (614) 224-8900 |
Annual Revenue (USD): | $100.000 to $499.999 |
Founded: | 1993 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Industry Specialist Consultants |
SIC Code: | 8742 |
NAICS Code: | 5416140 |
Share This Business: |
Medical Legal Review Inc was started in 1993 to provide professional Industry Specialist Consultants under the SIC code 8742 and NAICS code 5416140. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Carol Vollberg, Owner for inquiries that concern Medical Legal Review Inc by calling the company number (614) 224-8900, as your correspondence is most welcome. Additionally, the physical location of the single location of Medical Legal Review Inc can be found at the coordinates 39.950253,-82.998248 as well as the street address 580 South High St # 120 in Columbus, Ohio 43215.
For its online presence, you may visit Medical Legal Review Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.